A double-blind, 4-block randomized, placebo-controlled, adaptive phase 2/3 trial to confirm efficacy and safety of BLS-ILB-E710c in patients with cervical intraepithelial neoplasia 2/3 with extension study (1304)
Yung‐Taek Ouh, Seung Hun Song, Young Tae Kim, Chi‐Heum Cho, Tae Jin Kim, Seong Su Min, Do Young Lee, Young-Chul Park, Jae Kwan Lee